AU | EN
Current site :    AU   |   EN
Australia
Singapore

Thank you for submitting your query

We will be in touch soon to help you.

Explore our latest thinking and news below for deep insights and industry developments.

Explore Our Latest Thinking

Insight

Patent trends and the continuing strength of the Australian health tech sector

IP Australia has released its 14th annual Australian IP Report 2026 relating to intellectual property activity in 2025. In this article, we focus on trends in patent filings and the investment in patent protection. While overall patent filing volumes have stabilised, the standout story is the continuing strength of Australia's life sciences and health technology sector. Pharmaceuticals, medical technology, and biotechnology together account for one-third of all patent filings, and the sector's global significance continues to grow, accompanied by record biotech M&A activity as major pharma companies race to head off looming patent cliffs.

15 October 2026

Insight

Fixed election, floating duty? The stamp duty questions on the discretionary trust changes

On 3 September 2026, the Albanese Government released draft legislation for the new minimum 30% tax on discretionary trusts (trust distributions and capital gains) announced in the May Budget (see Mallesons Tax Alert on Discretionary Trusts here).

14 October 2026

Insight

Draft TCP Standard: A significant change is coming for Australian CSPs

On 29 September 2026, the Australian Communications and Media Authority (ACMA) released the consultation draft of the Telecommunications (Consumer Protections) Industry Standard 2026 (Draft TCP Standard). The final version of this Standard will ultimately replace the existing industry code, C628:2019 Telecommunications Consumer Protections Code (TCP Code).

14 October 2026

Explore Our Latest News

Deals

Mallesons leads 2026 M&A league tables in Australia and New Zealand

The firm also ranked #1 by deal volume in LSEG’s announced and completed league tables, while securing the #2 position by deal value across Asia-Pacific in both Mergermarket and LSEG announced rankings.

16 October 2026

Deals

Mallesons advises Permira on the A$3.4 billion sale of I-MED to Jardine Matheson 

Mallesons has advised Permira on its sale of I-MED Radiology to Jardine Matheson for A$3.4 billion. 

16 October 2026

Deals

Mallesons advises Glencore as global mining giant joins the ASX

Mallesons has advised Glencore plc (Glencore), one of the world’s largest diversified mining companies, on its secondary listing on the Australian Securities Exchange (ASX), bringing another major global resources company to the Australian market.

14 October 2026